Tuba GÖKDOĞAN EDGÜNLÜ, Sevim KARAKAŞ ÇELİK, Yüksel ERDAL, Osman Özgür YALIN, Aysun EROĞLU ÜNAL, Taşkın GÜNEŞ, Ufuk EMRE

Novel SNARE Complex Polymorphisms Associated with Multiple Sclerosis: Signs of Synaptopathy in Multiple Sclerosis

Background: It is well known that axonal degeneration plays a role in disability in patients with multiple sclerosis, and synaptopathy has recently become an important issue.Aims: To investigate the possible roles of selected synaptic and presynaptic membrane protein genetic polymorphisms (VAMP2, SNAP-25, synaptotagmin, and syntaxin 1A) in patients with multiple sclerosis.Study Design: Case-control study.Methods: A total of 123 patients with multiple sclerosis and 192 healthy controls were included. The functional polymorphisms of specific SNARE complex proteins (VAMP2, synaptotagmin XI, syntaxin 1A, and SNAP-25) were analyzed by polymerase chain reaction.Results: Significant differences were detected in the genotype and allele distribution of 26-bp Ins/Del polymorphisms of VAMP2 between patients with multiple sclerosis and control subjects; Del/Del genotype and Del allele of VAMP2 were more frequent in patients with multiple sclerosis (p=0.011 and p=0.004, respectively). Similarly, Ddel polymorphism of SNAP-25 gene C/C genotype (p=0.059), syntaxin 1A T/C and C/C genotypes (p=0.005), and synaptotagmin XI gene C allele (p=0.001) were observed more frequently in patients with multiple sclerosis. CC, syntaxin rs1569061 1A gene for 33-bp promoter region TC haplotypes, and synaptotagmin XI gene were found to be associated with an increased risk for multiple sclerosis (p=0.012). Similarly, GC haplotype for rs3746544 of SNAP-25 gene and rs1051312 of SNAP-25 gene were associated with an increased risk for multiple sclerosis (p=0.022).Conclusion: Genetic polymorphisms of SNARE complex proteins, which have critical roles in synaptic structure and communication, may play a role in the development of multiple sclerosis.

PDF

___

Lill CM. Recent advances and future challenges in the genetics of multiple sclerosis. Front Neurol 2014;14:130.
Compston A, Cloes A. Multiple Sclerosis. Lancet 2002;6:1221-31.
Baranzini SE. Revealing the genetic basis of multiple sclerosis: are we there yet? Curr Opin Genet Dev 2011;21:317-24.
Charcot JM. Lecons sur les maladies du systeme nerveux faites a la Salpetriere. Paris: A. Delahaye; 1880.
Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175-89.
Lassmann H. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 2010;225:2-8.
Owens T. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 2003;16:259-65.
De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121:1469-77.
Lee JY, Taghian K, Petratos S. Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability? Acta Neuropathol Commun 2014;2:97.
Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK. Animal models of multiple sclerosis--potentials and limitations. Prog Neurobiol 2010;92:386-404.
Srivastava P, Mujitaba MA, Singhal M. Gene and Cytokines Expression of Multiple Sclerosis and Its Therapeutic Regimen: A Systemic Review. Int J Drug Dev Res 2012;4:55-66.
Mandolesi G, Gentile A, Musella A, Fresegna D, De Vito F, Bullitta S, et al. Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nat Rev Neurol 2015;11:711-24.
Gitler D, Takagishi Y, Feng J, Ren Y, Rodriguiz RM, Wetsel WC, et al. Different presynaptic roles of synapsins at excitatory and inhibitory synapses. J Neurosci 2004;24:11368-80.
Bennett MK, Calakos N, Scheller RH. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 1992;257:255-9.
Söllner TH. Regulated exocytosis and SNARE function (Review). Mol Membr Biol 2003;20:209-20.
Barr CL, Feng Y, Wigg K, Bloom S, Roberts W, Malone M, et al. Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol Psychiatry 2000;5:405-9.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
Musella A, Mandolesi G, Mori F, Gentile A, Centonze D. Linking synaptopathy and gray matter damage in multiple sclerosis. Mult Scler 2016;22:146-9.
Jürgens T, Jafari M, Kreutzfeldt M, Bahn E, Brück W, Kerschensteiner M. Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis. Brain 2016;139;39-46.
Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006;67:960-7.
Dutta R, Chang A, Doud MK, Kidd GJ, Ribaudo MV, Young EA, et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011;69:445-54.
Vercellino M, Merola A, Piancentino C, Votta B, Capello E, Mancardi GL, et al. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007;66;723-9.
Liguori M, Cittadella R, Manna I, Valentino P, La Russa A, Serra P, et al. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis. J Neurol 2004;251:165-70.
Akkad DA, Gödde R, Epplen JT. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients. J Neurol 2006;253:1365-6.
Otaegui D, Zuriarrain O, Castillo-Trivino T, Aransay A, Ruíz-Martinez J, Olaskoaga J, et al. Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients. Mult Scler 2009;15:124-8.
Guerini FR, Bolognesi E, Chiappedi M, Manca S, Ghezzo A, Agliardi C, et al. SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders. Pharmacol Res 2011;64:283-8.
Barakauskas VE, Beasley CL, Barr AM, Ypsilanti AR, Li HY, Thornton AE, et al. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacol 2010;35:1226-38.
Gylys KH, Fein JA, Yang F, Wiley DJ, Miller CA, Cole GM. Synaptic changes in Alzheimer's disease: increased amyloid-β and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am J Pathol 2004;165:1809-17.
Yilmaz M, Edgunlu TG, Yilmaz N, Cetin ES, Celik SK, Emir GK, et al. Genetic variants of synaptic vesicle and presynaptic plasma membrane proteins in idiopathic generalized epilepsy. J Recept Sig Transduct Res 2014;34:38-43.
De Camilli P, Harris SM Jr, Huttner WB, Greengard P. Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immuno cytochemistry in agarose- embedded synaptosomes. J Cell Biol 1983;96:1355-73.
Liguori M, Cittadella R, Manna I, Valentino P, La Russa A, Serra P, et al. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis. J Neurol 2004;51:165-70.  
Ohmori O, Shinkai T, Hori H, Kojima H, Nakamura J. Synapsin III gene polymorphisms and schizophrenia. Neurosci Lett 2000;279:125-7.
Tsai MT, Hung CC, Tsai CY, Liu MY, Su YC, Chen YH, et al. Mutation analysis of synapsin III gene in schizophrenia. Am J Med Genet 2002;114:79-83.
Edgünlü TG, Özge A, Yalin OO, Kul S, Erdal ME. Genetic variants of Synaptic Vesicle and presynaptic plasma membrane proteins in Alzheimer’s disease. Archives of Neuropsychiatry 2012:49:294-299.
Corradini I, Verderio C, Sala M, Wilson MC, Matteoli M. SNAP-25 in neuropsychiatric disorders. Ann N Y Acad Sci 2009;1152:93-9.
Ullrich A, Böhme MA, Schöneberg J, Depner H, Sigrist SJ, Noé F. Dynamical Organization of Syntaxin-1A at the Presynaptic Active Zone. PLoS Comput Biol 2015;11:1004407.